|
RDL Clinical Trials Division provides
comprehensive laboratory services to meet the
dynamic needs of a broad range of biotechnology
and pharmaceutical clients. As a fully credentialed,
privately owned reference laboratory, we have
the unique ability to provide the research and
development community the personalized service
of a small company coupled with the emerging
technologies of top industry leaders. A relationship
with RDL means access to:
- Extensive Esoteric Test Menu
- Customized Assay Development
- Dedicated Project Management
- Scientific Consultation
- Unquestionable Quality Assurance
- Specimen Inventory and Storage
|
|
|
|
| |
|
|
 |
| |
|
|
| Dr. Robert Morris and Dr. Allan
Metzger have served as laboratory directors for
over twenty-five years. Drs. Morris and Metzger
are board certified in internal medicine and rheumatology
and have had over fifty years of combined experience
in the diagnosis and treatment of autoimmune disease.
In addition to having maintained private practices,
both physicians are on the clinical faculty of
UCLA School of Medicine. |
|
|
|
| |
|
|
|
| |
|
|
| Our scientists are second to none
in developing testing uniquely suited to your protocol.
Whether you require simple validations of existing
assays, predicate testing for your new technology,
or the creation of new assays using state-of-the-art
methodologies, our scientists are prepared. |
|
|
|
| |
|
|
|
| |
|
|
| In an age where the bottom line
is the only consideration, RDL has remained true
to its commitment to excellence. Over sixty percent
of our staff possesses Clinical Laboratory Scientist
licenses, advanced degrees in field, or both. We
keep costs down, but not at the expense of your
project. |
|
|
|
| |
|
|
|
| |
|
|
RDL’s leadership in the
field of Rheumatology makes us an invaluable
partner in your study of autoimmune and inflammatory
diseases. Our comprehensive list of services
ranges from basic autoantibody panels to full
patient monitoring including immune response,
cytokine analysis, and immunogenicity testing.
|
|
|
|
| |
|
|
|
| |
|
|
| Serum
Bank and Repository |
RDL has developed a vast, unique
collection of sera encompassing all the rheumatic
diseases both common and rare over the past two
decades. All specimens in the serum bank are
accompanied by diagnoses to ensure maximum clinical
relevance. In addition to the serum bank, RDL
maintains an even more extensive catalog of purely
serologically characterized specimens for all
known autoimmune markers. This collection enables
RDL to provide your study sufficient sample size
to ensure maximum statistical significance.
We are pleased to make the serum bank and repository
available to other investigators for collaborative
clinical studies and new assay development and
evaluation. |
|
|
|
| |
|
|
|
| |
|
|
For more information about RDL's
Clinical Trials Division, please contact:
John Sama
Director, Clinical Trials
(800) 338-1918
jsama@rdlinc.com |
|
|
|
| |
|
|
|
|
|
